/--SEA , and aa/aa) could be distinguished through the characteristic chromatograms generated by the WAVE system. The accuracy of this technique was evaluated blindly, and the results were 100% (40 of 40) concordant with the genotypes previously characterised by Southern blotting or Gap-PCR. Conclusions: This study validates the PCR/DHPLC approach as a simple, rapid, highly accurate, and cost effective method, potentially adaptable for use in epidemiological surveys, genetic screening, and diagnosis of silent a + thalassaemia and Hb H disease.
T he human a globin gene cluster on chromosome 16 consists of seven gene members including two major a globin genes-a2 and a1-which have almost identical coding sequences and are embedded within two highly homologous 4 kb duplicated units. These regions are divided into three homologous subsegments-X, Y, and Z boxes-by the non-homologous elements (I, II, and III). 1 2 Crossovers between misaligned X or Z boxes give rise to 2a 4.2 or 2a 3.7 chromosomes. These two deletional alleles are the most common single gene determinants producing asymptomatic/ silent carriers of a thalassaemia. In particular, a + thalassaemia, resulting from the 2a 4.2 deletion, is mainly distributed in certain areas of the tropics and subtropics including Melanesia, India, Southeast Asia, and southern China, with estimates of gene frequencies ranging from 2% to 60%. [3] [4] [5] ''In our study, we aimed to develop a new assay for the specific identification of the 2a 4.2 deletion based on the analysis of DNA sequence features around the breakpoint''
In Southeast Asia and southern China, the incidence of Hb H disease, which is caused by the co-inheritance of the cis a 0 thalassaemia deletion and the a + thalassaemia determinant, is relatively frequent because both the a 0 thalassaemia deletion (--SEA /) and a + thalassaemia alleles (2a 4.2 / and 2a 3.7 /) are very common in the population. 6 Traditionally, Southern blotting is the standard method used to detect gene deletions. However, it is time consuming, labour intensive, and is not feasible for large scale population screening. 7 In recent years, several techniques for the molecular characterisation of common a thalassaemia deletions have been described. [8] [9] [10] [11] The Gap-polymerase chain reaction (PCR) technique, based on the amplification of the junction segment of the breakpoint, is a notable example. However, there are problems with the reproducibility of this technique because PCR does not perform well for relatively long fragments with high G/C content. Thus, there is room for the development of new techniques that are highly accurate, rapid, inexpensive, automated, and easily interpretable, to aid in the diagnosis of a thalassaemia traits. This is especially relevant to the genotyping of a + thalassaemia deletions for epidemiological surveys, genetic screening, and the diagnosis of silent a thalassaemia carriers and Hb H disease, where there are no detectable phenotypic features. At present, the diagnosis of a + thalassaemia is only possible through the detection of Hb Bart's in cord blood samples by electrophoretic analysis. 12 The analysis of DNA by denaturing high performance liquid chromatography (DHPLC) is a relatively new method for the rapid detection and identification of point mutations. 13 14 In our study, we aimed to develop a new assay for the specific identification of the 2a 
DNA sequence analysis
The primers for amplifying the breakpoint region of the 2a 4.2 allele were P71 (59-TACCCATGTGGTGCCTCCATG-39) and P72 (59-TGTCTGCCACCCTCTTCTGAC-39), previously described by Oron-Karni et al, 8 which produced a 1596 bp PCR amplified product. The primers for amplifying the normal homologous segment in X box 2 were P71 and P3 (59-CCGACCTCAGGTGATCC TCT-39), which produced a 1302 bp PCR amplified product. P5 (59-GTTAAGCTGGA GCCTCGGTAG-39) and P72 were used to amplify the normal homologous segment in X box 1, producing a 1519 bp fragment. P3 and P5 were designed based on the a globin cluster sequence (accession number NG_000006) from National Center for Biotechnology Information (NCBI) GeneBank. Figure 1 shows the locations of these primers.
PCR was performed in a total volume of 50 ml containing 20 mmol/litre Tris/HCl (pH 8.4), 50 mmol/litre KCl, 1.5 mmol/litre MgCl 2 , 0.2 mM of each primer, 0.2 mmol/litre of each dNTP, 2.0 U of DNA polymerase (TaKaRa, LA Taq TM ; TaKaRa Biotechnology, Dalian, China), and 100 ng of genomic DNA. Reactions were carried out in a thermal cycler (PCR express thermal cycler; Hybaid Ltd, Ashford, Middlesex, UK), with an initial three minutes of denaturation at 95˚C; 30 cycles of 95˚C for 30 seconds, 62˚C for 40 seconds, 72˚C for one minute and 30 seconds; and a final extension at 72˚C for three minutes.
PCR products amplified from the 14 samples (10 samples with 2a
4.2 alleles and four aa haplotypes) used for the breakpoint sequence verification part of the study were directly sequenced using an ABI 377 sequencer (PE Biosystems; Foster City, California, USA) with BigDye terminator kit (PE Biosystems). The DNA sequences of the 2a 4.2 breakpoint region were aligned with the homologous sequences of the X boxes from both the Chinese healthy individuals we sequenced and the Homo sapiens genomic a globin region (HBA@) on chromosome 16 (NG_000006, GeneBank, NCBI) using the software DNAMAN 4.0 (Lynnon BioSoft Inc, Vandreuil, Quebec, Canada). The homologous DNA sequence from NG_000006 is from nt 30310 to nt 31656 (X2 box) or from nt 34567 to nt 35911 (X1 box). 15 16 PCR conditions for DHPLC analysis The primers used to produce the amplicons for DHPLC analysis were designed according to the newly found nucleotide variations linked to the 2a 4.2 allele in our study. These four variations were within the X2/X1 box of the 2a 4.2 breakpoint region. We designed a PCR system to amplify the DNA segment encompassing these four polymorphisms. The primers were D1 (59-CTCTGGGACCTCC TGGTGCTT-39) and D2 (59-CAGGAAGAGCGGGTGGTGGAG-39) (fig 1) , which produced a 312 bp PCR amplified fragment. Each 50 ml PCR mix contained the following components: 20 mmol/litre Tris/HCl, pH 8.4, 50 mmol/litre KCl, 1.5 mmol/ litre MgCl 2 , 25 pmol of each primer, 0.2 mmol/litre of each dNTP, 2 U polymerase (TaKaRa, c Taq TM ; TaKaRa Biotechnology), and 100 ng of genomic DNA. The reaction was carried out on a thermal cycler (PCR Express; Hybaid) with an initial three minutes of denaturation at 95˚C; 30 cycles of 95˚C for 30 seconds, 62˚C for 40 seconds, and 72˚C for 30 seconds; and a final extension at 72˚C for three minutes.
DHPLC analysis DHPLC analysis was conducted on the automated WAVE TM nucleic acid fragment analysis system (Transgenomic, Omaha, Nebraska, USA). The PCR product (5 ml) was injected into a preheated (61˚C) reversed phase column based on non-porous poly (styrene/divinylbenzene) particles (DNASep column; Transgenomic), and eluted from the column by a linear acetonitrile gradient at a flow rate of 0.9 ml/minute for seven minutes. The linear acetonitrile gradient consisted of 45% buffer A (0.1 mmol/litre triethylammonium acetate (TEAA); pH 7.0) and 55% buffer B (0.1 mol/litre TEAA; pH 7.0, containing 25% acetonitrile), and buffer B increased at 2%/minute. Fragments were eluted with the temperatures that were calculated by the DHPLC melt program for the successful resolution of heteroduplexes (http:/insertion.stanford.edu/). The DNA samples were typed by analysis of DHPLC distinct profiles.
RESULTS
Sequence alignment analysis showed that the DNA sequences of the segment encompassing the deletion breakpoint were identical in all 10 samples with the 2a 4.2 deletion. Figure 2 summarises these nucleotide variations. No sequence difference was found in the homologous segments involving two X boxes from the four normal Chinese individuals, and the sequences obtained from these four samples were identical to the sequence data from NG_000006. The DHPLC assay was subsequently designed to distinguish between the normal and the 2a 4.2 allele by exploiting the four nucleotide differences at the breakpoint region.
Samples with the 2a 4.2 /aa, 2a 4.2 /--SEA , and aa/aa genotypes could be clearly distinguished by the DHPLC chromatograms (fig 3) . Samples with the 2a 4.2 /--SEA genotype showed a single peak. This peak is representative of the 2a 4.2 allele because the corresponding -SEA allele lacked the segment involving the two X boxes. 2 17 In contrast, the 2a 4.2 / aa and aa/aa alleles revealed distinct DHPLC profiles. The chromatographic peaks generated from these genotypes are characterised by multiple double peaks. The double peaks are indicative of the presence of heteroduplexes, which are formed as the result of the presence of the nucleotide differences between the breakpoint region and the corresponding normal homologous regions (fig 3) .
The specificity and reliability of this newly developed DHPLC approach was compared with that of Gap-PCR or Southern blot analyses in a blind manner. The assay was performed on a total of 40 blood and prenatal DNA archival samples previously characterised by Gap-PCR or Southern blotting. The Gap-PCR or Southern blotting results were unknown until the genotypes obtained by DHPLC were scored. All of the 40 samples tested by DHPLC were found to be 100% concordant with the data obtained by the other two methods.
DISCUSSION
We have sequenced the breakpoint region of the 2a 4.2 allele and its normal homologous counterparts in the human a globin gene cluster from Chinese individuals. Interestingly, direct sequencing analysis of the 2a 4.2 deletion junction revealed four single nucleotide polymorphisms. We think that this variation is a conservative genetic event because these polymorphisms were present in all of the 10 2a DHPLC is a rapid, accurate, and semi-automated technique optimised for the screening of single base mutations, small DNA deletions, and insertions. The heteroduplex and homoduplex DNA fragments formed as a result of the presence or absence of sequence differences between complementary DNA fragments can be discriminated on the transgenomic DHPLC analyser under partial denaturing conditions. 13 18 Based on the novel sequence information on the four nucleotide polymorphic haplotypes linked to the 2a 4.2 allele in our study, we designed a PCR/DHPLC based method for the rapid genotyping of the 2a 4.2 thalassaemia deletion. As shown in fig 3, The results obtained by the DHPLC approach were 100% accurate for the identification of the 2a 4.2 deletion when compared with Southern blotting or Gap-PCR. The DHPLC approach enables the use of a single genomic template amplified in a single PCR reaction, with no need for labels for the accurate detection of the 2a 4.2 mutation. This represents a considerable reduction in labour and costs. The data generated by the WAVE system are easily interpretable and results are generated automatically within seven minutes. The high throughput would enable this technique to be adapted for large scale population screening. 14 The PCR/ DHPLC technology described in our study was designed for the specific detection of the unique polymorphic haplotype associated with the Chinese 2a 4.2 thalassaemia alleles will be analysed in future studies. These sequence data are not only useful for the development of molecular diagnostic approaches, but also provide a useful means for the study of human molecular evolution and genetic recombination mechanisms. 19 20 Our study indicates that the 2a 4.2 deletion is one of the most common a thalassaemia mutations in southern China, with a prevalence of approximately 1.0%, ranking third after the --SEA / and 2a 3.7 mutations. Consequently, Hb H disease is highly prevalent in southern China and poses a public health concern. Because of a lack of phenotypic features that are characteristic of a + thalassaemia, molecular genotyping is needed for the epidemiological survey, genetic screening, and diagnosis of a + thalassaemia carriers and individuals with Hb H disease. These aims could readily be achieved through the adoption of the new technology described here, which is well 
